This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is true of individual incentive plans as a reward system? A) They offer ... (Read 149 times)

kshipps

  • Hero Member
  • *****
  • Posts: 571
Which of the following is true of individual incentive plans as a reward system?
 
  A) They offer payment based on the overall performance of the organization.
  B) They produce lower performance as the group size increases.
  C) They pay workers based on the amount of output each worker generates.
  D) They tend to decrease competition.
  E) They encourage cooperation among workers.

Question 2

The Biblical view on employment is that ________.
 
  A) working for pay is wrong and one must abstain from doing so
  B) the poor need not be employed as God will look after them
  C) work had to be done only by the slaves in Jewish households
  D) the employment relationship is unlawful and exploitative
  E) work is the fulfillment of God's creative purpose



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

matt

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

C

Answer to Question 2

E




kshipps

  • Member
  • Posts: 571
Reply 2 on: Jul 6, 2018
YES! Correct, THANKS for helping me on my review


amcvicar

  • Member
  • Posts: 341
Reply 3 on: Yesterday
Excellent

 

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Did you know?

There are major differences in the metabolism of morphine and the illegal drug heroin. Morphine mostly produces its CNS effects through m-receptors, and at k- and d-receptors. Heroin has a slight affinity for opiate receptors. Most of its actions are due to metabolism to active metabolites (6-acetylmorphine, morphine, and morphine-6-glucuronide).

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

For a complete list of videos, visit our video library